PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
Clinical trial NCT05310734 · UNKNOWN
Trial details
- NCT number
- NCT05310734
- Sponsor
- Cipher Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2025-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.